ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
ERS Publications Podcasts29 Touko 2025

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-poliisin-mieli
docemilia
rss-duodecim-lehti
utelias-mieli
filocast-filosofian-perusteet
rss-laakaripodi
rss-opeklubi
rss-lihavuudesta-podcast
rss-sosiopodi
sotataidon-ytimessa
mielipaivakirja
radio-antro
rss-radplus
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita